文献速递区域麻醉与超声术前评估与围术期医学

1%盐酸氯普鲁卡因与高压布比卡因脊麻在日间肛肠手术中的比较:双盲随机临床试验

Comparison of 1% chloroprocaine hydrochloride versus hyperbaric bupivacaine spinal in patients undergoing anorectal surgery in an ambulatory surgery center: a double-blind randomized clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-05

该双盲随机对照试验纳入110例日间肛肠手术患者,比较1%氯普鲁卡因与0.75%布比卡因脊麻;氯普鲁卡因组达到出院标准时间显著短于布比卡因组,两组恢复时间无显著差异,24小时内均未记录到短暂神经症状。

要点

  • 氯普鲁卡因脊麻可缩短日间肛肠手术患者达到出院标准的时间。
  • 氯普鲁卡因与布比卡因在运动感觉恢复时间上无显著差异。
  • 两组24小时内均未记录到短暂神经症状。

核心结论

  • 与布比卡因相比,氯普鲁卡因显著缩短达到出院标准时间,且不增加短暂神经症状风险,支持用于日间肛肠手术脊麻。

研究设计与样本

  • 双盲随机对照试验,110例患者随机接受1%氯普鲁卡因或0.75%布比卡因脊麻,因无法置入脊麻排除5例(氯普鲁卡因组1例,布比卡因组4例)。

主要发现

  • 氯普鲁卡因组达到出院标准时间191.4±6.6 min,显著短于布比卡因组230.9±9.4 min(p<0.001)。
  • 两组恢复时间(运动和感觉功能恢复时间)无显著差异。
  • 两组术后24小时内均未记录到短暂神经症状。

关键数值与推荐

  • 共同主要终点为恢复时间(运动和感觉功能恢复时间)及达到出院标准时间。
  • 次要终点为短暂神经症状发生情况。

临床怎么用

  • 日间肛肠手术脊麻可考虑选用1%氯普鲁卡因以加快达到出院标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preservative-free chloroprocaine is a promising spinal anesthetic for ambulatory surgeries, offering a short duration of action and minimal side effects, which promote faster recovery and discharge. Thus, this study aimed to compare chloroprocaine hydrochloride to the widely used bupivacaine as a spinal anesthetic in ambulatory anorectal surgeries. We hypothesized that chloroprocaine will lead to quicker recovery and discharge, supporting its use in the ambulatory surgical setting. METHODS: In this double-blind randomized controlled trial, 110 patients were randomized to 1% chloroprocaine or 0.75% bupivacaine treatment groups. Due to the inability to place a spinal anesthetic, five patients were excluded (one in chloroprocaine and four in bupivacaine groups). The co-primary endpoints were recovery time (defined as the time of motor and sensory function return), and time discharge criteria were met. The secondary endpoint was the onset of transient neurological symptoms (TNS). RESULTS: The chloroprocaine group had a significantly shorter time to meet discharge criteria (191.4±6.6 min) than the bupivacaine group (230.9±9.4 min; p=<0.001). There were no significant differences between interventions for recovery time. No TNS were recorded within 24 hours after the procedure for both groups. CONCLUSION: Our study demonstrated a significantly reduced time to meeting discharge criteria with chloroprocaine compared with bupivacaine without an increased risk of TNS. Our results support the use of chloroprocaine for spinal anesthesia in ambulatory anorectal surgeries. TRIAL REGISTRATION NUMBER: NCT03324984.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Kim SW, Khandaker R, Muse IO, et al. Comparison of 1% chloroprocaine hydrochloride versus hyperbaric bupivacaine spinal in patients undergoing anorectal surgery in an ambulatory surgery center: a double-blind randomized clinical trial. Reg Anesth Pain Med. 2026. PMID: 39740957. doi:10.1136/rapm-2024-106130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。